5DX-15824-62940
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 336 / FL
- Registered
- 2022-09-25
- Relationship
- Child or adolescent in my care
- Guardian
- WDL-28049-55201
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-09-06
Dose 1 — ModernaCo-administered: Flu:Hib:Pneumonia
-
2022-09-25
Registered in v-safe
- 2022-09-25
- 2022-09-27
-
2022-10-04
Dose 2 — Moderna
- 2022-10-04
-
2022-10-05
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Site: Pain · Irritability/cryingUnder 3 check-in
- 2022-10-06
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-18
- 2022-10-25
-
2022-11-01
Survey response — day 28, dose 2, under 3MedDRA: Nasal congestion, Rhinorrhoea — Feeling: GoodFree text: Runny nose and some nasal congestion for 3 days.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-08
- 2022-11-15
- 2023-01-03
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-09-06 | Moderna | Flu:Hib:Pneumonia |
| 2 | 2022-10-04 | Moderna | No |
Free text
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Runny nose and some nasal congestion for 3 days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release